Published in Langenbecks Arch Surg on May 17, 2013
Surgical and interventional management of complications caused by acute pancreatitis. World J Gastroenterol (2014) 0.81
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest (1991) 16.06
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med (1998) 13.94
Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut (2012) 10.56
Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med (1995) 10.29
A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg (1993) 10.23
APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med (1981) 9.14
High serum procalcitonin concentrations in patients with sepsis and infection. Lancet (1993) 6.67
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis (2004) 6.65
Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet (1974) 5.15
Acute pancreatitis: value of CT in establishing prognosis. Radiology (1990) 4.07
A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg (1978) 3.91
APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet (1989) 3.88
Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet (2000) 3.16
Prognostic factors in acute pancreatitis. Gut (1984) 2.94
Acute pancreatitis: prognostic value of CT. Radiology (1985) 2.79
High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg (1999) 2.78
Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg (2002) 2.72
Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg (1985) 2.60
The timing of biliary surgery in acute pancreatitis. Ann Surg (1979) 2.56
Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg (1990) 2.36
Biliary surgery in the same admission for gallstone-associated acute pancreatitis. Br J Surg (1981) 2.29
ACUTE PANCREATITIS. Ann Surg (1925) 2.28
Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? A critical appraisal. Am J Gastroenterol (2001) 2.28
Computed tomography severity index, APACHE II score, and serum CRP concentration for predicting the severity of acute pancreatitis. JOP (2005) 2.25
Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut (2004) 2.12
C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg (1989) 2.11
Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med (2002) 2.01
Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas (2000) 1.97
Early prediction of acute pancreatitis: prospective study comparing computed tomography scans, Ranson, Glascow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers. World J Surg (2002) 1.87
A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England. Gut (2000) 1.87
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg (2006) 1.69
Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg (2001) 1.68
Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in China. World J Gastroenterol (2004) 1.67
A compaative study of methods for the prediction of severity of attacks of acute pancreatitis. Br J Surg (1980) 1.67
The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut (1997) 1.54
Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care (2005) 1.51
A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. AJR Am J Roentgenol (2004) 1.51
Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet (1990) 1.49
Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas (2001) 1.42
A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol (2011) 1.39
C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut (1987) 1.38
Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut (1995) 1.33
Objective early identification of severe acute pancreatitis. Am J Gastroenterol (1974) 1.33
Prognostic usefulness of scoring systems in critically ill patients with severe acute pancreatitis. Crit Care Med (1999) 1.26
Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med (2001) 1.18
Prediction of mortality in acute pancreatitis: a systematic review of the published evidence. Pancreatology (2009) 1.13
Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Pancreatology (2004) 1.12
Role of early multisystem organ failure as major risk factor for pancreatic infections and death in severe acute pancreatitis. Clin Gastroenterol Hepatol (2006) 1.12
Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg (2007) 1.09
Evaluation of severity in patients with acute pancreatitis. Am J Gastroenterol (1992) 1.08
Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology (2001) 1.06
Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg (2005) 1.05
Severe acute pancreatitis: prognostic factors in 270 consecutive patients. Pancreas (2000) 1.02
Comparison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitis. Pancreas (2002) 1.02
Prediction of the severity of acute pancreatitis. Am J Surg (1993) 0.98
Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol (1986) 0.98
Extrapancreatic inflammation on abdominal computed tomography as an early predictor of disease severity in acute pancreatitis: evaluation of a new scoring system. Pancreas (2007) 0.97
Factors predicting mortality in severe acute pancreatitis. Pancreatology (2003) 0.97
Risk factors in acute pancreatitis. Am J Gastroenterol (1983) 0.96
Laboratory markers of severe acute pancreatitis. Dig Dis (2004) 0.96
Acute pancreatitis: radiologic scores in predicting severity and outcome. Abdom Imaging (2009) 0.95
Perioperative factors determine outcome after surgery for severe acute pancreatitis. Crit Care (2004) 0.94
Value of the different prognostic systems and biological markers for predicting severity and progression of acute pancreatitis. Scand J Gastroenterol (2010) 0.94
Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Arch Surg (2001) 0.93
Risk of death from acute pancreatitis. Role of early, simple "routine" data. Int J Pancreatol (1996) 0.92
A comparison of the Ranson, Glasgow, and APACHE II scoring systems to a multiple organ system score in predicting patient outcome in pancreatitis. Am J Surg (2005) 0.92
Machine learning can improve prediction of severity in acute pancreatitis using admission values of APACHE II score and C-reactive protein. Pancreatology (2005) 0.91
Clinical characteristics and prognostic factors of severe acute pancreatitis. World J Gastroenterol (2004) 0.90
Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas (2002) 0.89
Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis. Br J Surg (1993) 0.88
Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med (2000) 0.87
Simplified prognostic criteria in acute pancreatitis. Pancreas (1986) 0.87
Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg (2004) 0.86
Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut (2002) 0.86
Evaluation of the clinical usefulness of APACHE II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study. Pancreas (1993) 0.85
Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg (2004) 0.83
Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study. Am J Gastroenterol (2002) 0.82
Recent advances in the surgical management of necrotizing pancreatitis. Curr Opin Crit Care (2005) 0.82
Comparative evaluation of the modified CT severity index and CT severity index in assessing severity of acute pancreatitis. AJR Am J Roentgenol (2011) 0.81
Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models. Pancreatology (2003) 0.80
Clinical implications derived from the morphological classification of 89 patients with acute pancreatitis. J Clin Gastroenterol (1983) 0.80
Severity scoring for prognostication in patients with severe acute pancreatitis: comparative analysis of the Ranson score and the APACHE III score. Arch Surg (2002) 0.80
Acute pancreatitis in intensive care unit patients: value of clinical and radiologic prognosticators at predicting clinical course and outcome. Crit Care Med (2003) 0.79
Acute pancreatitis in the aged. Aust N Z J Surg (1988) 0.79
Early physiological response to intensive care as a clinically relevant approach to predicting the outcome in severe acute pancreatitis. Arch Surg (2004) 0.79
Acute pancreatitis in elderly patients. Pathogenesis and outcome. Am J Surg (1986) 0.79
Prognostic indicators in acute pancreatitis: CT vs APACHE II. Clin Radiol (1997) 0.78
Monitoring of serum proteinase--antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis. Results of a prospective multicenter study. Dig Dis Sci (1993) 0.78
Evaluation of Ranson, Glasgow, APACHE-II, and APACHE-O criteria to predict severity in acute biliary pancreatitis. Int Surg (2002) 0.78
VIII. The Diagnosis and Treatment of Acute Pancreatitis. Ann Surg (1903) 0.77
Hematocrit determination (HCT) as an early marker associated with necrotizing pancreatitis and organ failure. Pancreas (2001) 0.77
Factors predisposing to severe acute pancreatitis: evaluation and prevention. World J Gastroenterol (2003) 0.76
Admission hematocrit: a simple, useful and early predictor of severe pancreatitis. Dig Dis Sci (2005) 0.76
Correlation between admission laboratory values, early abdominal computed tomography, and severe complications of gallstone pancreatitis. Am J Surg (2000) 0.75
Acute pancreatitis in patients over 80 years. Eur J Surg (1996) 0.75
Scoring systems for predicting outcome in acute hemorrhagic necrotizing pancreatitis. Eur J Surg (1992) 0.75
Failure of the Hong Kong criteria to predict the severity of acute pancreatitis. Int J Pancreatol (1997) 0.75
Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg (2013) 5.12
Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Res (2002) 2.35
Severe acute pancreatitis: Clinical course and management. World J Gastroenterol (2007) 1.55
Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Liver Transpl (2002) 1.51
Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR. Surgery (2003) 1.41
Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum (2006) 1.35
Transformation of the microvascular system during multistage tumorigenesis. Int J Cancer (2002) 1.30
Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. Clin Cancer Res (2005) 1.29
Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol (2007) 1.16
Cryopreservation of human colorectal carcinomas prior to xenografting. BMC Cancer (2010) 1.14
Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg (2002) 1.13
Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol (2003) 1.11
Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG. PLoS One (2012) 1.06
R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use. Surgery (2012) 1.05
RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome? Surgery (2002) 1.04
Limits of Couinaud's liver segment classification: a quantitative computer-based three-dimensional analysis. J Comput Assist Tomogr (2002) 1.01
Determinant-based classification of severity of acute pancreatitis: have we really reached consensus? Ann Surg (2015) 1.00
Ischemic preconditioning by brief extremity ischemia before flap ischemia in a rat model. Plast Reconstr Surg (2002) 0.98
Sustained hypothermia accelerates microvascular thrombus formation in mice. Am J Physiol Heart Circ Physiol (2005) 0.98
Distinct effects of acute and chronic nicotine application on microvascular thrombus formation and endothelial function in male and female mice. Langenbecks Arch Surg (2007) 0.96
Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg (2007) 0.93
Hepatic platelet and leukocyte adherence during endotoxemia. Crit Care (2006) 0.92
Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases. Pancreatology (2008) 0.92
Impact of portal branch ligation on tissue regeneration, microcirculatory response and microarchitecture in portal blood-deprived and undeprived liver tissue. Microvasc Res (2011) 0.91
Primary human hepatocytes are protected against complement by multiple regulators. Mol Immunol (2009) 0.88
Pancreatic capillary blood flow in an improved model of necrotizing pancreatitis in the rat. J Surg Res (2002) 0.88
Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO). J Biomed Biotechnol (2010) 0.86
Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma. Strahlenther Onkol (2004) 0.85
Bacteriolytic therapy of experimental pancreatic carcinoma. World J Gastroenterol (2010) 0.85
A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig. J Endovasc Ther (2007) 0.84
Postoperative care following pancreatic surgery: surveillance and treatment. Dtsch Arztebl Int (2009) 0.84
Is the lymph node ratio superior to the Union for International Cancer Control (UICC) TNM system in prognosis of colon cancer? World J Surg Oncol (2013) 0.84
Intensified irinotecan-based neoadjuvant chemoradiotherapy in rectal cancer: four consecutive designed studies to minimize acute toxicity and to optimize efficacy measured by pathologic complete response. Radiother Oncol (2007) 0.83
Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer. World J Gastroenterol (2004) 0.83
Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries. J Surg Res (2007) 0.82
Systemic hypothermia increases PAI-1 expression and accelerates microvascular thrombus formation in endotoxemic mice. Crit Care (2006) 0.82
Generation of highly pure fusions of colorectal carcinoma and antigen-presenting cells. Langenbecks Arch Surg (2010) 0.82
Duodenum-preserving total pancreatic head resection for cystic neoplasm: a limited but cancer-preventive procedure. Langenbecks Arch Surg (2008) 0.82
Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study. Crit Care (2011) 0.82
DTG procurement guidelines in heart beating donors. Transpl Int (2011) 0.82
New advances in pancreatic surgery. Curr Opin Gastroenterol (2007) 0.82
Iliac anastomotic stenting with a biodegradable poly-L-lactide stent: a preliminary study after 1 and 6 weeks. J Endovasc Ther (2006) 0.81
Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications. BMC Surg (2013) 0.81
Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis. Oncotarget (2014) 0.81
Darbepoetin-alpha does not promote microvascular thrombus formation in mice: role of eNOS-dependent protection through platelet and endothelial cell deactivation. Arterioscler Thromb Vasc Biol (2007) 0.81
Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis. Surgery (2004) 0.81
Radiation-induced leukocyte adhesion to endothelium in normal pancreas and in pancreatic carcinoma of the rat. Int J Cancer (2003) 0.80
Different radiogenic effects on microcirculation in healthy pancreas and in pancreatic carcinoma of the rat. Ann Surg (2003) 0.80
Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort. Eur J Clin Pharmacol (2010) 0.80
The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines. World J Gastroenterol (2004) 0.80
Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks. J Endovasc Ther (2006) 0.80
Axillary-axillary interarterial chest loop conduit as an alternative for chronic hemodialysis access. J Vasc Surg (2005) 0.80
Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis. BMC Cancer (2013) 0.80
The "North German Tumor Bank of Colorectal Cancer": status report after the first 2 years of support by the German Cancer Aid Foundation. Langenbecks Arch Surg (2013) 0.80
Volume-outcome relationship in pancreatic surgery: the situation in Germany. Surgery (2012) 0.79
Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose. J Antimicrob Chemother (2006) 0.79
Induction of an antitumoral immune response by wild-type adeno-associated virus type 2 in an in vivo model of pancreatic carcinoma. Pancreas (2007) 0.79
Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation. Surgery (2011) 0.79
Effective antitumoral immune responses are not induced by cytosine deaminase suicide gene transfer in a syngeneic rat pancreatic carcinoma model. Eur Surg Res (2006) 0.79
Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients. Int J Colorectal Dis (2007) 0.79
Treatment of necrotizing pancreatitis: redefining the role of surgery. World J Surg (2012) 0.79
C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat. Microvasc Res (2004) 0.79
Ciclosporin aggravates tissue damage in ischemia reperfusion-induced acute pancreatitis. Pancreas (2006) 0.79
Identification of differentially expressed genes after partial rat liver ischemia/reperfusion by suppression subtractive hybridization. World J Gastroenterol (2005) 0.79
Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res (2006) 0.79
Quantification of liver perfusion by dynamic magnetic resonance imaging: experimental evaluation and clinical pilot study. Liver Transpl (2009) 0.79
Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation. Transplantation (2003) 0.78
Oxygen radicals promote ICAM-1 expression and microcirculatory disturbances in experimental acute pancreatitis. Pancreatology (2003) 0.78
Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancer. Eur J Cancer (2006) 0.78
Multidrug strategies are effective in the treatment of severe experimental pancreatitis. Surgery (2011) 0.78
Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature. Transpl Int (2013) 0.78
Combining bacterial-immunotherapy with therapeutic antibodies: a novel therapeutic concept. Vaccine (2012) 0.78
Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR. Int J Cancer (2003) 0.77
Induction of HSP70 shows differences in protection against I/R injury derived by ischemic preconditioning and intermittent clamping. Microvasc Res (2010) 0.77
Donor pretreatment with gadolinium chloride improves early graft function and survival after porcine liver transplantation. Transpl Int (2003) 0.76
Microvascular dysfunction in hepatic ischemia-reperfusion injury in pigs. Microvasc Res (2010) 0.76
Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction. World J Surg (2001) 0.76
A novel sialyl Le(X) expression score as a potential prognostic tool in colorectal cancer. World J Surg Oncol (2012) 0.76
Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma. BMC Immunol (2011) 0.76
Bacterial immunotherapy of gastrointestinal tumors. Langenbecks Arch Surg (2011) 0.76
Future perspectives for surgical research in Germany. Langenbecks Arch Surg (2014) 0.75
Laparoscopic treatment of renal artery entrapment. J Vasc Surg (2010) 0.75